HER2 (erb B-2)-targeted effects of the ω-3 polyunsaturated. Fatty acid α-linolenic acid (ALA; 18:3n-3) in breast cancer cells: The 〈fat features〉 of the 〈Mediterranean diet〉 as an 〈anti-HER2 cocktail〉

Clinical and Translational Oncology

Volumn 8, Issue 11, 2006, Pages 812-820

  Menéndez, Javier A ^a,b,c   Vázquez Martín, Alejandro ^a,b,c   Ropero, Santiago ^d   Colomer, Ramón ^a,b,c   Lupu, Ruth ^b,e   Trueta, Josep ^f  

^a GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f Robert H Lurie Comprehensive Cancer Center of Northwestern University ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CERVONIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LINOLENIC ACID; LUCIFERASE; MEDIUM CHAIN FATTY ACID; MESSENGER RNA; MONOUNSATURATED FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROTEIN P185; TRASTUZUMAB; ANTINEOPLASTIC AGENT; EDIBLE OIL; MONOCLONAL ANTIBODY; TUMOR PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CARCINOMA CELL; CELL ASSAY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MEDITERRANEAN DIET; METASTASIS POTENTIAL; ONCOGENE; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; VALIDATION STUDY; WESTERN BLOTTING; BIOSYNTHESIS; BREAST TUMOR; DRUG ANTAGONISM; ENZYME INDUCTION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PROTO ONCOGENE; TUMOR CELL LINE;

ALPHA-LINOLENIC ACID; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; DIET, MEDITERRANEAN; DIETARY FATS, UNSATURATED; DOWN-REGULATION; DRUG SYNERGISM; ENZYME INDUCTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VITAMIN E;

EID: 34249876936     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-006-0137-2     Document Type: Article

References (40)

1. Bougnoux P, Koscielny S, Chajes V, Descamps P, Couet C, Calais G. Alphalinolenic acid content of adipose tissue: A host determinant of the risk of early metastasis in breast cancer. Br J Cancer. 1994;70:330-4.
2. Klein V, Chajes V, Germain E, et al. Low alpha-linolenic acid content of adipose tissue is associated with an increased risk of breast cancer. Eur J Cancer. 2000;56: 555-40.
3. Kamano K, Okuyama H, Konishi R, Nagasawa H. Effects of a high-linoleate and high-alpha-linolenate on spontaneous mammary tumorigenesis in mice. Anti-cancer Res. 1989;9:1903-8.
4. Fritsche KL, Johnston PV. Effect of dietary alpha-linolenic acid on growth, metastasis, fatty acid profile and prostaglandin production of two murine mammary adenocarcinomas. J Nutr. 1999;120:1601-9.
5. Hirose M, Masuda A, Ito N, Kamano K, Okuyama H. Effects of dietary perilla oil, soybean oil and safflower oil on 7,12-dimethylbenz(a) anthracene (DMBA) and 1,2-domethylhydrazine (DMH)-induced mammary gland and colon carcinogenesis in female SD rats. Carcinogenesis. 1990; 11:731-5.
6. Munoz SF, Silva RA, Lamarque A, Guzmán CA, Eynard AR. Protective capability of dietary Zizyphus mistol seed oil, rich in 18/3 n-3, on the development of two murine mammary gland adenocarcinomas with high and low metastatic potential. Prostaglandins Leukot Essent Fatty Acids. 1995;53:135-8.
7. Chajes V, Sattler W, Stranzl A, Kostner GM. Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: Relationship to peroxides and vitamin E. Breast Cancer Res Treat. 1995; 34:199-212.
8. Thompson LU, Chen JM, Strasser-Weippl K, Goss PE. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005;11: 3828-35.
9. Yamamoto T, Ikawa S, Akiyama T, et al. Similarity of protein encoded by the human c- erb B-2 gene to epidermal growth factor receptor. Nature. 1986;319:230-4.
10. Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature. 1986;319:226-30.
11. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235:177-82.
12. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989;244:707-12.
13. Ross JS, Fletcher JA. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells. 1998;16:413-28.
14. Di Fiore PP, Pierce JH, Kraus MH, et al. erb B-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science. 1987; 237:178-82.
15. Hudziak RN, Schlessinger J, Ullrich A. Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sci USA. 1987;84: 7159-63.
16. Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and-nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material. Mod Pathol. 2002;15:116-24.
17. Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, et al. Her2/neu gene amplification in ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2002;11:587-90.
18. Tan M, Yao J, Yu D. Overepression of the c- erb B-2 gene enhanced intrinsic metastasis potencial in human breast cancer cells without increasing their transformation abilities. Cancer Res. 1997;57:1199-205.
19. Eccles SA. The role of c- erb B-2/HER2/neu in breast cancer progression and metastasis. J Mammary Gland Biol Neoplasia, 2001;6:393-406.
20. Yakes FM, Chinratanalab W, Ritter CA, et al. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt is required for antibody-mediated effects on p27, cyclin D1, and antitumor action. Cancer Res. 2002;62:4152-41.
21. Kraus MH, Popescu NC, Amsbaugh SC, et al. Overexpression of the EGF receptor-related proto-oncogene erb B-2 in human mammary tumour cell lines by different molecular mechanisms. EMBO J. 1987;6:605-10.
22. Bates NP, Hurst HC. Transcriptional regulation of type 1 receptor tyrosine kinases in the mammary gland. J Mammary Gland Biol Neoplasia. 1997;2:153-63.
23. Hurst HC. Update on HER-2 as a target for cancer therapy. The erb B-2 promoter and its exploitation for cancer treatment. Breast Cancer Res. 2001;3:395-8.
24. HER2 antibody for human cancer therapy. Proc Natl Acad Sci USA. 1992;89:4285-9.
25. Baselga J, Tripathy D, Mendelsohn J, et al. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol. 1996;14:737-44.
26. Cobleigh MA, Vogel CL, Tripathy D, et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol. 1999;17:2639-48.
27. Vogel CL, Cobleigh MA, Tripathy D, et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2002;20:719-26.
28. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpress HER2. N Engl J Med 2001;544:785-92.
29. Ross JS, Fletcher JA, Bloom KJ, et al. Targeted therapy in breast cancer: The HER-2/neu gene and protein. Mol Cell Proteomics. 2004;3:379-98.
30. Nahta R, Yu D, Hung MC, Hortobagyi GN, Esteva FJ. Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat Clin Pract Oncol. 2006;3:269-80.
31. Wahle KW, Rotondo D, Heys SD. Polyunsaturated fatty acids and gene expression in mammalian systems. Proc Nutr So. 2003;62:349-60.
32. Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci. 2004; 41:41-78.
33. Pégorier JP, Le May C, Girard J. Control of gene expression by fatty acids. J Nutr. 2004;154:2444S-9S.
34. Menendez JA, Ropero S, Lupu R, Colomer R. Dietary fatty acids regulate the activation status of Her-2/neu (c- erb B-2) oncogene in breast cancer cells. Ann Oncol. 2004;15:1719-21.
35. Menéndez JA, Lupu R, Colomer R. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:n-3) synergistically enhances taxanes cytotoxicity and downregulates Her-2/ neu (c- erb B-2) oncogene expression in human breast cancer cells. Eur J Cancer Prev. 2005;14:263-70.
36. Menéndez JA, Vellón L, Colomer R, Lupu R. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erb B-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Ann Oncol. 2005;16:359-71.
37. Menéndez JA, Vellón L, Colomer R, Lupu R. Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erb B-2) oncogene. J Natl Cancer Inst. 2005;97:1611-5.
38. Menéndez JA, Papadimitropoulou A, Vellón L, Colomer R, Lupu R. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: Oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA 3 DNA binding site" complexes at the Her-2/neu (erb B-2) oncogene promoter in breast, ovarian and stomach cancer cells. Eur J Cancer. 2006 Jan 4 [Epub ahead of print].
39. Menéndez JA, Lupu R. RESPONSE: Re: Effect of-Linolenic Acid on the Transcriptional Activity of the Her-2/neu (erb B-2) Oncogene. J Natl Cancer Inst. 2006;98:718-20.
40. Bougnoux P, Giraudeau B, Couet C. Diet, cancer and the lipidome. Cancer Epidemiol Biomarkers Prev. 2006;15:416-21.